PMID: 616069Oct 1, 1977Paper

The effect of mexiletine on the electrophysical properties of the intact human heart

Scandinavian Journal of Clinical and Laboratory Investigation
R W HarperE Varnauskas

Abstract

The effect of an intravenous dose of mexiletine, a new anti-arrhythmic agent, on the electrophysiological properties of the intact human heart was studied in ten subjects with no evidence of cardiovascular disease. Mexiletine produced no significant changes in the sinus node recovery time, the corrected sinus node recovery time or in the atrial, atrio-ventricular and ventricular effective refractory periods. In addition mexiletine had no significant effect on proximal atrioventricular conduction. The drug did, however, prolong atrio-ventricular conduction distal to the bundle of His in all ten subjects by an average of 6 msec. This change was statistically significant (P less than 0.01). The drug is recommended to be used with caution in patients with conduction disturbances.

References

Jan 1, 1972·Circulation·O S NarulaR P Javier
Aug 25, 1973·Lancet·R G TalbotL F Prescott
Aug 25, 1973·Lancet·N P CampbellJ F Pantridge
Feb 1, 1973·The American Journal of Cardiology·H H HechtT B Watt
May 1, 1973·Circulation·M MirowskiA I Mendeloff
Jan 1, 1973·British Journal of Pharmacology·A Clark, C B Olson
May 6, 1974·The American Journal of Cardiology·M E JosephsonA N Damato
Sep 1, 1970·Progress in Cardiovascular Diseases·A N Damato, S H Lau
Jan 1, 1972·British Journal of Pharmacology·B N Singh, E M Vaughan Williams
Aug 1, 1972·British Journal of Pharmacology·J D AllenS A Zaidi
Sep 1, 1971·British Heart Journal·S BekheitE Fletcher
Jan 1, 1969·Circulation·B J ScherlagA N Damato
Jan 1, 1974·The Journal of Physiology·J A Allen, I C Roddie
Jun 1, 1974·British Journal of Clinical Pharmacology·M A KiddieT R Shaw

❮ Previous
Next ❯

Citations

Feb 1, 1979·British Heart Journal·N P CampbellJ F Pantridge

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiac Conduction System

The cardiac conduction system is a specialized tract of myocardial cells responsible for maintaining normal cardiac rhythm. Discover the latest research on the cardiac conduction system here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Related Papers

British Journal of Clinical Pharmacology
M A KiddieT R Shaw
British Journal of Clinical Pharmacology
N P CampbellR G Shanks
JAMA : the Journal of the American Medical Association
E G Abinader, M Cooper
© 2021 Meta ULC. All rights reserved